Background Routine use of whole‐cell pertussis (wP) vaccines was suspended in some
countries in the 1970s and 1980s because of concerns about adverse effects. Following this …

Objective: To assess the efficacy and safety of whole-cell and acellular pertussis vaccines
administered to children singly or within diphtheria, tetanus and pertussis (DTP) vaccines …

In anticipation of the successful eradication of wild polio virus, alternative vaccination
strategies for public-sector markets of low-resource countries are extremely important, but …

The immunogenicity and reactogenicity of booster vaccination with GSK Biologicals'
hexavalent DTPa-HBV-IPV/Hib vaccine was assessed in toddlers aged 12–18 months …

Background. We compared the safety and immunogenicity of two combined
diphtheriatetanus-pertussis-inactivated poliovirus vaccines containing either acellular (Pa …

Objectives. To determine the reactogenicity and immunogenicity of a fourth dose of 2 three-
component acellular pertussis vaccines combined with diphtheria-tetanus-acellular …

A trial to compare the reactogenicity and immunogenicity of a reduced antigen content
diphtheria–tetanus–acellular pertussis (dTpa) vaccine with diphtheria–tetanus–whole-cell …

Pertussis remains a serious problem in many countries. Even in countries with high vaccine
coverage and a long vaccination history, pertussis outbreaks occur periodically. Rather than …

Materials and methods We prepared a review according to the Preferred Reporting Items for
Systematic Reviews and Meta-Analyses (PRISMA) with the aims of: a) describing the …

A tricomponent acellular pertussis vaccine containing pertussis toxoid, filamentous
hemagglutinin, and pertactin combined with diphtheria and tetanus toxoids (DTPa) was …